The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
- 9 July 1992
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (2), 76-81
- https://doi.org/10.1056/nejm199207093270203
Abstract
Primary pulmonary hypertension is a progressive, fatal disease of unknown cause. Vasodilator drugs have been used as a treatment, but their efficacy is uncertain.This publication has 21 references indexed in Scilit:
- High dose titration of calcium channel blocking agents for primary pulmonary hypertension: Guidelines for short-term drug testingJournal of the American College of Cardiology, 1991
- Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.Circulation, 1990
- Primary pulmonary hypertensionProgress in Cardiovascular Diseases, 1988
- High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.Circulation, 1987
- The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.Circulation, 1985
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984
- The natural history of idiopathic pulmonary hypertensionThe American Journal of Cardiology, 1981
- Pulmonary Hemodynamics in Primary Pulmonary HypertensionJapanese Heart Journal, 1979
- PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTORHeart, 1958
- Primary pulmonary hypertensionAmerican Journal Of Medicine, 1951